Consumer Health in Belgium
CONSUMER HEALTH IN BELGIUM
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Executive Summary
Differing Fates for OTC Products and Other Consumer Health
Non-otc Products Also Have Their Own Constraints
Generic, Medium-sized And/or Local Manufacturers Fare Better Than Ethical Multinationals
Movement Within Distribution
Manufacturers Remain Wary of Future Legislation
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 2 Life Expectancy at Birth 2013-2018
Market Data
Table 3 Sales of Consumer Health by Category: Value 2013-2018
Table 4 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 5 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 6 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 8 Distribution of Consumer Health by Format: % Value 2013-2018
Table 9 Distribution of Consumer Health by Format and Category: % Value 2018
Table 10 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Definitions
Sources
Summary 2 Research Sources
Headlines
Prospects
Analgesics Increasingly Susceptible To the Vagaries of the Weather
Patches and Fast-acting Products Could Prevent Saturation in Topical Analgesics/anaesthetics
Dangerous Secondary Effect of Increasing Unit Price
Competitive Landscape
Further Erosion of Mainstream Brands
Active Substances Are Becoming Brand Names, Which Benefits Generics
Brands Focus on Niche Products and New Formats
Category Data
Table 12 Sales of Analgesics by Category: Value 2013-2018
Table 13 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 14 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 15 NBO Company Shares of Analgesics: % Value 2014-2018
Table 16 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 17 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 18 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
Headlines
Prospects
the "sleep Hormone" Should Maintain Dynamism
Virtuous Cycle of Energy and Calming Products
Fighting Stress Should Remain A Crucial Need
Competitive Landscape
Metagenics Belgium at the Head of A Dynamic Trio
Sanofi-Synthélabo Enters Category
Dynamic Brands Offer Competition To Newcomers
Category Data
Table 19 Sales of Sleep Aids: Value 2013-2018
Table 20 Sales of Sleep Aids: % Value Growth 2013-2018
Table 21 NBO Company Shares of Sleep Aids: % Value 2014-2018
Table 22 LBN Brand Shares of Sleep Aids: % Value 2015-2018
Table 23 Forecast Sales of Sleep Aids: Value 2018-2023
Table 24 Forecast Sales of Sleep Aids: % Value Growth 2018-2023
Headlines
Prospects
Increasingly Uncertain Impact of the Weather on Respiratory Infections and Sales
Switches May Have Undesirable Secondary Effects
Antihistamines/allergy Remedies (systemic) Performs Fairly Well
Competitive Landscape
Sanofi Leader As Gbo Ahead of Medicated Confectionery Players
Non-profitable Advertising and Limited Innovation
Success Story of Toularynx Continues
Category Data
Table 25 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 26 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 27 Sales of Decongestants by Category: Value 2013-2018
Table 28 Sales of Decongestants by Category: % Value Growth 2013-2018
Table 29 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 30 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Headlines
Prospects
Promoting Self-medication Could Be the Solution
OTC Dermatologicals Facing Competition From All Sides
Too Small To Be Profitable
Competitive Landscape
Janssen-cilag Leads But Remains Loyal To Traditional Strategies
Advertising Important Strategy for Antifungals
Similar B2c Strategies for Other Dynamic Players
Category Data
Table 33 Sales of Dermatologicals by Category: Value 2013-2018
Table 34 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 35 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 36 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 37 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 38 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 39 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023
Headlines
Prospects
Main Growth Drivers Not As Initially Expected
Travel Remedies and Laxatives Are Steady Performers
Burden of the Past
Competitive Landscape
Janssen-cilag Retains Leadership
Gaviscon Progresses in Antacids
Local Players Often Fare Better Than Multinationals
Category Data
Table 40 Sales of Digestive Remedies by Category: Value 2013-2018
Table 41 Sales of Digestive Remedies by Category: % Value Growth 2013-2018
Table 42 NBO Company Shares of Digestive Remedies: % Value 2014-2018
Table 43 LBN Brand Shares of Digestive Remedies: % Value 2015-2018
Table 44 Forecast Sales of Digestive Remedies by Category: Value 2018-2023
Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2018-2023
Headlines
Prospects
Eye Care Players Push for Self-medication
Artificial Tears Should Fare Better Than Allergy Eye Care and "sensitive" Products
Eye Health Supplements To Remain Non-negligible Indirect Competitors
Competitive Landscape
Théa Pharma Leads Eye Care
Disparate Performance Due To Short-term Success
Testing Proves Effective Strategy
Category Data
Table 46 Sales of Eye Care by Category: Value 2013-2018
Table 47 Sales of Eye Care by Category: % Value Growth 2013-2018
Table 48 Sales of Standard Eye Care by Format: % Value 2013-2018
Table 49 Sales of Standard Eye Care by Positioning: % Value 2013-2018
Table 50 NBO Company Shares of Eye Care: % Value 2014-2018
Table 51 LBN Brand Shares of Eye Care: % Value 2015-2018
Table 52 Forecast Sales of Eye Care by Category: Value 2018-2023
Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2018-2023
Headlines
Prospects
E-cigarettes Pose Serious Threat Despite Tough Local Legislation
Only New and Fast-acting Formats Have A Chance To Succeed
Belgium Not Ready To Adopt the Eur10 Pack
Competitive Landscape
Janssen-cilag Is Most Impacted by the Bleak Performance of 2018
Niquitin Manages To Rebound While Nicotinell Collapses
Limited Innovation and Focus on Tactical Advertising
Category Indicators
Table 54 Number of Smokers by Gender 2013-2018
Category Data
Table 55 Sales of NRT Smoking Cessation Aids by Category: Value 2013-2018
Table 56 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2013-2018
Table 57 Sales of NRT Gum by Flavour: % Value 2013-2018
Table 58 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2014-2018
Table 59 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2015-2018
Table 60 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 61 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023
Headlines
Prospects
More Favourable Weather During Spring and Summer Could Be A Real Ally
Specific Products Remain Limited
Continuous Price Erosion
Competitive Landscape
Beiersdorf Retains Leadership of Wound Care
3m Remains the Main Challenger in Chemists/pharmacies
Wound Care Is the Exception for Private Label
Category Data
Table 62 Sales of Wound Care by Category: Value 2013-2018
Table 63 Sales of Wound Care by Category: % Value Growth 2013-2018
Table 64 NBO Company Shares of Wound Care: % Value 2014-2018
Table 65 LBN Brand Shares of Wound Care: % Value 2015-2018
Table 66 Forecast Sales of Wound Care by Category: Value 2018-2023
Table 67 Forecast Sales of Wound Care by Category: % Value Growth 2018-2023
Headlines
Prospects
Sports Nutrition To Be in Constant Evolution
Ongoing Revolution in Distribution
New Products, Consumer Segments and Areas With Potential
Competitive Landscape
Qnt Continues To Strengthen Its Position
Mixed Results for Most Other Players
Modern Grocery Retailers and Private Label Lines Increasingly Interested
Category Data
Table 68 Sales of Sports Nutrition by Category: Value 2013-2018
Table 69 Sales of Sports Nutrition by Category: % Value Growth 2013-2018
Table 70 NBO Company Shares of Sports Nutrition: % Value 2014-2018
Table 71 LBN Brand Shares of Sports Nutrition: % Value 2015-2018
Table 72 Forecast Sales of Sports Nutrition by Category: Value 2018-2023
Table 73 Forecast Sales of Sports Nutrition by Category: % Value Growth 2018-2023
Headlines
Prospects
Players Appear To Face Pressure From Efsa
Some Products Remain Under Scrutiny
Reduced Lifecycles and Competition From Other Products
Competitive Landscape
Mixed Results for Leader Merck Consumer Healthcare
Femannose Contributes To Dynamism of Women's Health
Medium-sized and Local Players More Reactive
Category Data
Table 74 Sales of Dietary Supplements by Category: Value 2013-2018
Table 75 Sales of Dietary Supplements by Category: % Value Growth 2013-2018
Table 76 Sales of Dietary Supplements by Positioning: % Value 2013-2018
Table 77 Sales of Fish Oils/Omega Fatty Acids by Type: % Value 2013-2018
Table 78 NBO Company Shares of Dietary Supplements: % Value 2014-2018
Table 79 LBN Brand Shares of Dietary Supplements: % Value 2015-2018
Table 80 Forecast Sales of Dietary Supplements by Category: Value 2018-2023
Table 81 Forecast Sales of Dietary Supplements by Category: % Value Growth 2018-2023
Headlines
Prospects
Favourable Outlook Due To New Opportunities in Single Vitamins
No Improvement Expected Due To Disaffection for Multivitamins
Outlook for Segmented Multivitamins Darkens
Competitive Landscape
Galephar Consolidates Its Freshly Acquired Leadership
Historic Multivitamins Operators Yield Ground But Stay Afloat
Sanofi Exits Multivitamins
Category Data
Table 82 Sales of Vitamins by Category: Value 2013-2018
Table 83 Sales of Vitamins by Category: % Value Growth 2013-2018
Table 84 Sales of Multivitamins by Positioning: % Value 2013-2018
Table 85 NBO Company Shares of Vitamins: % Value 2014-2018
Table 86 LBN Brand Shares of Vitamins: % Value 2015-2018
Table 87 Forecast Sales of Vitamins by Category: Value 2018-2023
Table 88 Forecast Sales of Vitamins by Category: % Value Growth 2018-2023
Headlines
Prospects
Doubts Over Ability To Increase Sustainably
Finding Credible Natural Claims Is Difficult
Belgium Offers Less Room for Growth Than Other Countries
Competitive Landscape
Xl-s by Omega Pharma Belgium Almost Alone in Supporting Sales
Fleeting Success
Promising Launch of Elimin Turn & Go
Category Data
Table 89 Sales of Weight Management and Wellbeing by Category: Value 2013-2018
Table 90 Sales of Weight Management and Wellbeing by Category: % Value Growth 2013-2018
Table 91 NBO Company Shares of Weight Management and Wellbeing: % Value 2014-2018
Table 92 LBN Brand Shares of Weight Management and Wellbeing: % Value 2015-2018
Table 93 Forecast Sales of Weight Management and Wellbeing by Category: Value 2018-2023
Table 94 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2018-2023
Headlines
Prospects
Herbal/traditional Products To Gain in Popularity and Distribution
Persistent Interference From Efsa and Local Authorities
Impact of Lack of Ailments
Competitive Landscape
Tilman Stands Out From the Crowd
Aggressive Promotions Are An Effective Strategy
Category Data
Table 95 Sales of Herbal/Traditional Products by Category: Value 2013-2018
Table 96 Sales of Herbal/Traditional Products by Category: % Value Growth 2013-2018
Table 97 NBO Company Shares of Herbal/Traditional Products: % Value 2014-2018
Table 98 LBN Brand Shares of Herbal/Traditional Products: % Value 2015-2018
Table 99 Forecast Sales of Herbal/Traditional Products by Category: Value 2018-2023
Table 100 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2018-2023
Headlines
Prospects
Category Under Pressure and With Limited Profitability at First Sight
Paediatric Analgesics Could Be A Shelter for Branded Players
Paediatric Digestives Will Find It Difficult To Recover
Competitive Landscape
Ethical Players Notably Specialising in Analgesics Logically Dominate
Continual Limited Innovation
Medical Devices Emerge for Children
Category Data
Table 101 Sales of Paediatric Consumer Health by Category: Value 2013-2018
Table 102 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018
Table 103 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018
Table 104 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018
Table 105 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018
Table 106 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 107 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
Once again, the status of consumer health – OTC remedy or non-OTC: vitamins and dietary supplements, weight management and wellbeing and sleep aids – made the difference in 2018. The number and strength of ailments that rely on climatic conditions play key roles in the sales of the former. After a stagnant 2017 without high incidences of cold or influenza cases, the number of general practitioners’ consultations for respiratory infections increased in 2018 from mid-February to mid-March and then...
Euromonitor International's Consumer Health in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.